Every trial result rests on biometrics: the clinical data management, biostatistics and statistical programming work that turns raw trial data into decision-ready evidence. That work is changing faster than it...
As consumer technology continues to advance, wearable or portable smart devices are becoming increasingly accessible, contributing to the rapid emergence of digital biomarkers in modern healthcare, as well as a...
The finger tap test is one of the oldest and most widely used motor assessments in clinical neuroscience. A clinician watches a patient tap as quickly as possible for a...
Healthcare systems worldwide are increasingly shifting toward data-driven models integrated with digital health technologies (DHTs) and artificial intelligence (AI). This shift is reflected in the rapid growth of the global...
Insights from new peer-reviewed research by Koneksa during Parkinson's Awareness Month Behind Every Dataset is a Lived Experience. In Parkinson’s disease, symptoms do not progress in neat, linear steps....
Introduction The adoption of digital biomarkers in clinical trials is accelerating rapidly, driven by wearable sensors, decentralized trial models, and the demand for continuous patient monitoring. As sponsors increasingly explore...
Diversity in clinical trials is not only a social imperative, it is a scientific standard. February, during Black History Month, offers an important moment to reflect on both the historical...
Clinical development has never had more tools at its disposal. Wearables, sensors, mobile apps, imaging, biomarkers, and real-world data streams are increasingly used to generate digital endpoints in clinical trials,...
We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is...
Dear Friends, As the year comes to a close, we are grateful for the progress we have made toward our vision of developing digital measures that benefit patients and are...
In the same week that the Michael J. Fox Foundation (MJFF) held its 14th annual Parkinson’s Disease (PD) Therapeutics Conference in New York City, Koneksa held its inaugural PD Day....
This year’s International Parkinson and Movement Disorder Society (MDS) was held over the last weekend of September in Philadelphia. The theme, “Movement Disorders in the Digital Age: Harnessing AI for...
We were privileged to attend the 7th Annual Digital Biomarkers in Clinical Trials Summit at the Roche Headquarters in Basel on June 26th, 2024. Over 300 attendees attended the consortium,...
Last week, two important events happened, both hosted by the Critical Path Institute (C-Path): the Electronic Clinical Outcome Assessment (eCOA) Consortium meeting on April 16, and the 2024 Clinical Outcome...
The American Society for Clinical Pharmacology & Therapeutics(ASCPT) hosted a Patient Forum on March 28 at the 2024 annual meeting. I was privileged to chair the discussion, which centered on...